LNC
EXAS

Lincoln National Corp’s Exact Sciences EXAS Stock Holding History

Lincoln National Corp’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,358
Closed -$370K – 346
2024
Q1 		$370K Sell
5,358
-2,459
-31% -$156K 0.01% 867
2023
Q4 		$578K Buy
7,817
+570
+8% +$37.4K 0.01% 622
2023
Q3 		$494K Buy
7,247
+989
+16% +$83.9K 0.01% 606
2023
Q2 		$588K Buy
6,258
+255
+4% +$19.9K 0.01% 547
2023
Q1 		$407K Buy
6,003
+644
+12% +$41.4K 0.01% 659
2022
Q4 		$265K Buy
+5,359
New +$219K 0.01% 768
2022
Q3 		– Sell
-5,315
Closed -$209K – 884
2022
Q2 		$209K Buy
5,315
+420
+9% +$22.5K ﹤0.01% 795
2022
Q1 		$342K Sell
4,895
-107
-2% -$7.82K 0.01% 679
2021
Q4 		$389K Sell
5,002
-249
-5% -$22K 0.01% 618
2021
Q3 		$501K Buy
5,251
+297
+6% +$31.4K 0.01% 499
2021
Q2 		$616K Sell
4,954
-1,070
-18% -$128K 0.01% 430
2021
Q1 		$794K Hold
6,024
– – 0.02% 337
2020
Q4 		$798K Buy
6,024
+98
+2% +$11.9K 0.02% 318
2020
Q3 		$604K Buy
5,926
+229
+4% +$19.8K 0.02% 345
2020
Q2 		$495K Sell
5,697
-106
-2% -$8.47K 0.02% 375
2020
Q1 		$337K Buy
5,803
+1,006
+21% +$81.7K 0.01% 418
2019
Q4 		$444K Buy
4,797
+415
+9% +$36.5K 0.01% 419
2019
Q3 		$396K Hold
4,382
– – 0.01% 397
2019
Q2 		$517K Sell
4,382
-500
-10% -$50.4K 0.02% 315
2019
Q1 		$423K Sell
4,882
-2,226
-31% -$189K 0.02% 323
2018
Q4 		$449K Hold
7,108
– – 0.02% 288
2018
Q3 		$561K Sell
7,108
-450
-6% -$29.3K 0.02% 250
2018
Q2 		$452K Sell
7,558
-1,532
-17% -$82.4K 0.02% 283
2018
Q1 		$367K Sell
9,090
-11,646
-56% -$568K 0.01% 321
2017
Q4 		$1.09M Buy
20,736
+10,368
+100% +$554K 0.03% 218
2017
Q3 		$489K Buy
10,368
+264
+3% +$10.6K 0.02% 219
2017
Q2 		$357K Buy
10,104
+728
+8% +$22.5K 0.02% 238
2017
Q1 		$221K Buy
+9,376
New +$186K 0.01% 301

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Lincoln National Corp's EXAS Position: Q2 2024 in Review

Lincoln National Corp sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 5,358 shares — an estimated $370K sold.

Lincoln National Corp first reported a position in EXAS in Q1 2017 and held it in 28 quarters. The position peaked at $1.09M in Q4 2017. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Lincoln National Corp reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 5,358 Exact Sciences shares in Q2 2024, an estimated $370K.
  • Lincoln National Corp first reported a position in Exact Sciences in Q1 2017 and held it in 28 quarters.
  • Lincoln National Corp's Exact Sciences position peaked at $1.09M in Q4 2017.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.